Why Covid Is Surging Again In The UK And What It Means For The Economy

As the UK heads into winter, a familiar set of symptoms—runny noses, coughs, fevers—are sweeping through households and workplaces. Recent data highlight that these afflictions are largely driven by a resurgence in Covid-19 cases, underpinned by a combination of factors including waning immunity, the emergence of a new variant and behavioural shifts.

This autumn, attention is squarely on the XFG strain of the virus, also known as Stratus, which currently accounts for the majority of Covid cases both in the UK and across the globe. Data from the UK Health Security Agency reveal XFG is responsible for over 70 per cent of domestically recorded cases, while the World Health Organisation has attributed over 60 per cent of global Covid cases to this variant. Its modest 31 per cent growth advantage over previous variants, while significant, is relatively restrained compared to the 200 per cent growth advantage seen with the initial Omicron wave. As a result, while Stratus is a clear driver, it is not the only one pushing infection rates upwards.

The level of population immunity to Covid has notably fallen. Monitoring indicates that cases are at their highest since last November. With free mass testing consigned to the past, about nine per cent of all tests taken in early September produced a positive result. Following infection, antibodies typically last only a few months, underscoring the cyclical nature of Covid surges. Importantly, a considerable proportion of the population is now experiencing asymptomatic or less severe cases compared to earlier years, partly the result of accrued immunity from previous infections and vaccination.

School reopenings signal another risk vector, reinvigorating transmission rates among children and subsequently entire households. There is potential for an autumn peak reminiscent of October last year, after which influenza supplanted Covid as the primary winter viral threat.

Mitigation strategies remain broadly unchanged. Hand hygiene, cleaning shared surfaces and, for vulnerable individuals, mask-wearing in crowded settings are recommended. At-risk groups—including care home residents, the over-75s and immunocompromised individuals—should take up the autumn booster through the national vaccination programme starting in October. Experts reiterate the high effectiveness of current vaccines at reducing severe illness and community spread.

Most people experiencing Covid are advised to rest at home, hydrate and manage symptoms with standard over-the-counter medication. Worsening symptoms or persistent illness should prompt medical advice, and antivirals are available for those with high-risk conditions. Self-isolation is encouraged, particularly to protect vulnerable contacts, and individuals with symptoms should avoid those at heightened risk for at least ten days.

It is important to note that symptoms such as coughs, sore throats and fevers may also derive from other viral infections including rhinoviruses, adenoviruses and parainfluenza. These are currently as prevalent, if not more so, than Covid, resulting in clinical uncertainty without formal testing. Clear identification of the infection remains beneficial for both clinical outcomes and public health management.